Lipocine Inc — Quarterly Financial Statistics (NASDAQ:LPCN) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -2.83 M1.7 M-1.97 M-1.89 M-2.99 M -5.14 M Cash from investing activities 1.02 M761.06 K-882.07 K4.5 M701.45 K 5.08 M Cash from financing activities 00075.62 K141.33 K 216.95 K Free cash flow -2.91 M1.69 M-1.97 M-1.89 M-2.99 M -5.15 M

뉴스

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C. 웨인라이트, 라이포신 목표 주가 15달러로 상향 조정

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

리포신, 긍정적 안전성 검토 후 PPD 약물 임상 지속

Lipocine’s PPD drug trial continues after positive safety review

리포신, 산후 우울증 치료제 임상 80% 등록 완료

Lipocine reaches 80% enrollment in postpartum depression drug trial

리포신, AES 연례 회의서 LPCN 2101 간질 후보 물질 데이터 발표

Lipocine presents LPCN 2101 epilepsy candidate data at annual AES meeting

리포신, 3상 임상 PPD 치료제 긍정적 안전성 평가 발표